| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.0049 | 1 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |